📰 Ed Esplin News
Ed Esplin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ed Esplin. Real-time updates on events, politics, business and more.
May 23, 2024
/PRNewswire/ -- Invitae (OTC:NVTAQ), a leading medical genetics company, today announced eight studies to be presented at the 2024 American Society of Clinical...
April 11, 2024
/PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced new studies to be presented at the American Society of Breast Surgeons...
December 11, 2023
Prophylactic removal of the ovaries and fallopian tubes is now the recommended way to treat certain people at high risk of ovarian cancer. I’m about to find out what it’s like.
May 26, 2023
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced nine studies to be presented at the 2023 American Society of Clinical...
September 15, 2022
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, joined other clinical experts in releasing a new commentary in Journal of Clinical...
September 15, 2022
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, joined other clinical experts in releasing a new commentary in Journal of Clinical...
May 26, 2022
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced eight studies to be presented at the 2022 American Society of...
May 26, 2022
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced eight studies to be presented at the 2022 American Society of...